Drugs Made In America Acquisition LLC sold DMAA
January 29, 2025 · Form 4 insider transaction
Drugs Made In America Acquisition LLC sold 5,698,363 shares of Drugs Made In America Acquisition Corp., a transaction worth N/A. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 6 days after the transaction.
Direction
Disposed (sell-side)
Shares
5,698,363
Price
N/A
Total value
N/A
Role—
SecurityOrdinary shares
Transaction codeS: Open-market sale
Transaction dateJanuary 29, 2025
Filing dateFebruary 4, 2025
Shares owned after4,158,780
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
As of the Transaction Date, pursuant to share transfer agreements, the reporting person transferred an aggregate of 5,698,363 ordinary shares for consideration ranging from no consideration to $1.50 per share.